34D.F 101.75 (+1.24%)
IT0003492391• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. 34D.F

Diasorin (34D.F) Competitor Comparison

We are evaluating the key criteria listed to compare Diasorin (34D.F) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 55

Dividend yield

0 / 8

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Linearity 5 years - 34D.F ranking 0 / 58

These are the competitors of Diasorin in the industry Diagnostics & Research ranked by linearity 5 years
1. CareDx CDNA
156.3
2. Co-Diagnostics CODX
100.26
3. Charles River Laboratories CRL
52.59
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. DarioHealth DRIO
31.71
6. Inotiv NOTV
29.39
7. Syneos Health SYNH
24.79
8. Fulgent Genetics FLGT
22.92
9. Icon ICLR
15.82
10. Heska HSKA
15.42
11. IQVIA Holdings IQV
10.38
12. Olink Holding OLK
8.53
13. Pacific Biosciences of California PACB
7.99
14. Qiagen QGEN
7.41
15. DexCom DXCM
6.98
16. Anixa Biosciences ANIX
6.16
17. Aspira Womens Health AWH
5.9
18. IDEXX Laboratories IDXX
5.57
19. Quest Diagnostics DGX
5.16
20. PerkinElmer PKI
4.97
21. Trinity Biotech TRIB
4.91
22. Exact Sciences EXAS
4.72
23. Mettler-Toledo MTD
4.36
24. Personalis PSNL
4.04
25. Guardant Health GH
3.95
26. Laboratory Corp of America Holdings LH
3.88
27. Illumina ILMN
3.82
28. Twist Bioscience TWST
3.79
29. Myriad Genetics MYGN
3.69
30. Agilent Technologies A
3.61
31. Danaher DHR
3.61
32. NeoGenomics NEO
3.6
33. Enzo Biochem ENZ
3.59
34. Thermo Fisher Scientific TMO
3.58
35. Sotera Health SHC
3.56
36. Neogen NEOG
3.34
37. Sera Prognostics SERA
3.02
38. Bioventus BVS
2.88
39. Waters WAT
2.67
40. National Research NRC
2.59
41. Interpace Biosciences IDXG
2.45
42. Precipio PRPO
2.44
43. Psychemedics PMD
2.32
44. Neuronetics STIM
2.28
45. Global Cord Blood CO
2.23
46. MaxCyte MXCT
2.15
47. MDxHealth MDXH
1.99
48. Biodesix BDSX
1.88
49. Exagen XGN
1.87
50. Prenetics Global PRE
1.78
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Medpace Holdings MEDP
0.74
56. RadNet RDNT
0.6
57. Natera NTRA
0.59
58. Lantheus Holdings LNTH
0.43
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.